INMB (INmune Bio) Short-term investments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

INMB INmune Bio Inc INMB
57 GF Score
Price $1.74
GF Value $1.80
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is INmune Bio Short-term investments?

Short-term investments only applies to insurance companies.

INMB
57GF Score
INmune Bio Inc INMB
Short-term investments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is INmune Bio (INMB) Overvalued in 2026?

Based on GuruFocus' analysis, INmune Bio stock appears to be undervalued. The current stock price of $1.74 is trading 3.6% below its estimated GF Value™ of $1.80. GuruFocus considers INmune Bio to be Fairly Valued.

Key valuation signals for INMB:

  • Short-term investments:
  • GF Value™: $1.80 vs. price of $1.74 (3.6% below fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the INMB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


INmune Bio Business Description

Address 225 NE Mizner Boulevard, Suite 640, Boca Raton, FL, USA, 33432
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
57GF Score

Get the complete analysis for INMB

Short-term investments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.74
Price
$1.80
GF Value